Device Trial Radar · NCT04388332
ACDF Using Structural Allograft vs. Tritanium C
Last checked: Nov 19, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Aug 20, 2020
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- VB Spine, LLC
- First posted
- May 14, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an observational, descriptive, prospective and retrospective data collection study. The purpose of this study is to observe radiographic outcomes of patients who will undergo anterior cervical discectomy and fusion (ACDF) utilizing Tritanium C (Stryker Spine). The rate of fusion success and adverse events will be compared retrospectively to patients who underwent instrumented ACDF utilizing structural allograft bone with plates.
Conditions
- Degenerative Disc Disease
Interventions
Structural allograftProcedure
Subjects that have received ACDF structural allograft with plates with autograft and/or allograft comprised of cancellous and/or corticocancellous bone chips
Tritanium CDevice
Subjects will receive the Tritanium C anterior cervical cage which is intended to be used with autogenous or allogenic bone graft comprised of cancellous and/or corticocancellous bone graft
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to the presence of fusionTime frame: 3 months post-operatively
- Time to the presence of fusionTime frame: 6 months post-operatively
- Time to the presence of fusionTime frame: 12 months post-operatively
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Allegheny Health Network
Pittsburgh, Pennsylvania · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.